Form 4 for KPRX KIORA PHARMACEUTICALS INC
Accepted 2024-08-20 00:00:00 ET · period of report 2024-08-19 · accession 0001372514-24-000111 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-20 | 2024-08-19 | KPRX | Walters-Hoffert Lisa | Dir | P - Purchase | $3.86 | +1,250 | 1,250 | New | +$4,825 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-19 | P | A | 1,250 | $3.86 | 1,250 | D | — | — | (F1) The shares were purchased in multiple transactions at prices ranging from $3.815 to $3.8798. The reported price of $3.86 represents the volume weighted average price for the reported transaction. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |